Long-Term Treatment with Potassium Citrate and Renal Stones in Medullary Sponge Kidney | Zendy

Antonia Fabris | Zendy; Antonio Lupo | Zendy; Patrizia Bernich | Zendy; Cataldo Abaterusso | Zendy; Nicola Marchionna | Zendy; Antonio Nouvenne | Zendy; Giovanni Gambaro | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Long-Term Treatment with Potassium Citrate and Renal Stones in Medullary Sponge Kidney

Author(s) -

Antonia Fabris,

Antonio Lupo,

Patrizia Bernich,

Cataldo Abaterusso,

Nicola Marchionna,

Antonio Nouvenne,

Giovanni Gambaro

Publication year - 2010

Publication title -

clinical journal of the american society of nephrology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.755

H-Index - 151

eISSN - 1555-905X

pISSN - 1555-9041

DOI - 10.2215/cjn.00220110

Subject(s) - medicine , hyperuricosuria , hypercalciuria , kidney stones , nephrocalcinosis , urology , distal renal tubular acidosis , uric acid , urinary system , renal tubular acidosis , calcium oxalate , urinary calcium , acidosis , kidney , gastroenterology

Medullary sponge kidney (MSK) is a renal malformation typically associated with nephrocalcinosis and recurrent calcium stones. Incomplete distal renal tubular acidosis, hypocitraturia, and hypercalciuria are common. For stone prevention, patients with MSK generally receive the standard "stone clinic" recommendations and often receive potassium citrate (KC). However, the effect on stone recurrence of citrate treatment in these patients has never been studied.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research